Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Genitourinary 2Classical hematology 2

Conditions

Ovarian Neoplasms 535Uterine Cervical Neoplasms 249Fallopian Tube Neoplasms 239Endometrial Neoplasms 142Carcinoma, Ovarian Epithelial 135Breast Neoplasms 101Neoplasms 74Carcinoma, Non-Small-Cell Lung 70Colorectal Neoplasms 53Uterine Cervical Dysplasia 49Papillomavirus Infections 49Neoplasm Metastasis 48Pancreatic Neoplasms 46Melanoma 44Uterine Neoplasms 43Prostatic Neoplasms 41Urinary Bladder Neoplasms 40Lung Neoplasms 40Stomach Neoplasms 38Peritoneal Neoplasms 37Recurrence 36Carcinoma, Renal Cell 35Triple Negative Breast Neoplasms 33Head and Neck Neoplasms 32Esophageal Neoplasms 31Small Cell Lung Carcinoma 30Sarcoma 28Vulvar Neoplasms 26Vaginal Neoplasms 24Testicular Neoplasms 22

Interventions

ulipristal acetate 2Rocuronium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Leiomyoma × Gynecologic × Clear all
NCT02812186 2020-04-08

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Stony Brook University

Phase 4 Completed
79 enrolled 9 charts
GenitourinaryGynecologic

Cholecystitis, Endometriosis, Intestinal Obstruction, Leiomyoma, Prostatic Neoplasms, Uterine Prolapse, Renal Insufficiency, Chronic

NCT02147158 2019-06-04

A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas

Allergan

Phase 3 Completed
432 enrolled 16 charts
Gynecologic

Leiomyoma, Uterine Hemorrhage

NCT02147197 2019-04-30

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Allergan

Phase 3 Completed
157 enrolled 11 charts
Gynecologic

Leiomyoma, Uterine Hemorrhage

NCT00628901 2012-07-11

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)

Boston Scientific Corporation

Phase 4 Completed
60 enrolled 39 charts
Gynecologic

Leiomyoma, Menorrhagia, Uterine Neoplasms, Leiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡